Jianzhijia Pharmaceutical Chain Group Balance Sheet Health
Financial Health criteria checks 3/6
Jianzhijia Pharmaceutical Chain Group has a total shareholder equity of CN¥2.8B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 118%. Its total assets and total liabilities are CN¥10.7B and CN¥7.9B respectively. Jianzhijia Pharmaceutical Chain Group's EBIT is CN¥417.7M making its interest coverage ratio 3.3. It has cash and short-term investments of CN¥760.6M.
Key information
118.0%
Debt to equity ratio
CN¥3.25b
Debt
| Interest coverage ratio | 3.3x |
| Cash | CN¥760.62m |
| Equity | CN¥2.76b |
| Total liabilities | CN¥7.95b |
| Total assets | CN¥10.71b |
Recent financial health updates
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt
Oct 03
Recent updates
Further Upside For Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Could Introduce Price Risks After 33% Bounce
Nov 12We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt
Oct 03What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?
Jul 16Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%
Jun 19Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet
Feb 27Financial Position Analysis
Short Term Liabilities: 605266's short term assets (CN¥4.7B) do not cover its short term liabilities (CN¥5.5B).
Long Term Liabilities: 605266's short term assets (CN¥4.7B) exceed its long term liabilities (CN¥2.4B).
Debt to Equity History and Analysis
Debt Level: 605266's net debt to equity ratio (90.4%) is considered high.
Reducing Debt: 605266's debt to equity ratio has increased from 12.9% to 118% over the past 5 years.
Debt Coverage: 605266's debt is well covered by operating cash flow (25.1%).
Interest Coverage: 605266's interest payments on its debt are well covered by EBIT (3.3x coverage).